Proteomic analysis of diabetic retinas

Introduction As a metabolic disease, diabetes often leads to health complications such as heart failure, nephropathy, neurological disorders, and vision loss. Diabetic retinopathy (DR) affects as many as 100 million people worldwide. The mechanism of DR is complex and known to impact both neural and vascular components in the retina. While recent advances in the field have identified major cellular signaling contributing to DR pathogenesis, little has been reported on the protein post-translational modifications (PTM) - known to define protein localization, function, and activity - in the diabetic retina overall. Protein glycosylation is the enzymatic addition of carbohydrates to proteins, which can influence many protein attributes including folding, stability, function, and subcellular localization. O-linked glycosylation is the addition of sugars to an oxygen atom in amino acids with a free oxygen atom in their side chain (i.e., threonine, serine). To date, more than 100 congenital disorders of glycosylation have been described. However, no studies have identified the retinal O-linked glycoproteome in health or disease. With a critical need to expedite the discovery of PTMomics in diabetic retinas, we identified both global changes in protein levels and the retinal O-glycoproteome of control and diabetic mice. Methods We used liquid chromatography/mass spectrometry-based proteomics and high throughput screening to identify proteins differentially expressed and proteins differentially O-glycosylated in the retinas of wildtype and diabetic mice. Results Changes in both global expression levels of proteins and proteins differentially glycosylated in the retinas of wild-type and diabetic mice have been identified. We provide evidence that diabetes shifts both global expression levels and O-glycosylation of metabolic and synaptic proteins in the retina. Discussion Here we report changes in the retinal proteome of diabetic mice. We highlight alterations in global proteins involved in metabolic processes, maintaining cellular structure, trafficking, and neuronal processes. We then showed changes in O-linked glycosylation of individual proteins in the diabetic retina.

[1]  J. Coon,et al.  N-glycoproteomics of brain synapses and synaptic vesicles , 2023, Cell reports.

[2]  M. Gorbatyuk,et al.  Posttranslational modifications of proteins in diseased retina , 2023, Frontiers in Cellular Neuroscience.

[3]  T. Zhou,et al.  N‐cadherin cleavage: A critical function that induces diabetic retinopathy fibrosis via regulation of β‐catenin translocation , 2023, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  Junlong Zhang,et al.  Functional regulation of syntaxin-1: An underlying mechanism mediating exocytosis in neuroendocrine cells , 2023, Frontiers in Endocrinology.

[5]  Y. Lo,et al.  Alleviative effects of α‐lipoic acid on muscle atrophy via the modulation of TNF‐α/JNK and PI3K/AKT pathways in high‐fat diet and streptozotocin‐induced type 2 diabetic rats , 2023, Food science & nutrition.

[6]  Xiang Ren,et al.  O-GlcNAc Modification and Its Role in Diabetic Retinopathy , 2022, Metabolites.

[7]  Christian Rosenmund,et al.  Syntaxin-1A modulates vesicle fusion in mammalian neurons via juxtamembrane domain dependent palmitoylation of its transmembrane domain , 2022, bioRxiv.

[8]  M. Gorbatyuk,et al.  Diabetic Retinopathy: From Animal Models to Cellular Signaling , 2022, International journal of molecular sciences.

[9]  M. Athar,et al.  A Novel Tree Shrew Model of Diabetic Retinopathy , 2022, Frontiers in Endocrinology.

[10]  R. Simó,et al.  Neuromodulation Induced by Sitagliptin: A New Strategy for Treating Diabetic Retinopathy , 2021, Biomedicines.

[11]  Ramkumar Veppathur Mohan,et al.  Pancreatic β-Cell O-GlcNAc Transferase Overexpression Increases Susceptibility to Metabolic Stressors in Female Mice , 2021, Cells.

[12]  Neha S. Gandhi,et al.  Phosphorylation and O-GlcNAcylation of the PHF-1 Epitope of Tau Protein Induce Local Conformational Changes of the C-Terminus and Modulate Tau Self-Assembly Into Fibrillar Aggregates , 2021, Frontiers in Molecular Neuroscience.

[13]  S. Akira,et al.  Tribbles Homolog 3 Mediates the Development and Progression of Diabetic Retinopathy , 2021, Diabetes.

[14]  F. Alkuraya,et al.  Pathogenic STX3 variants affecting the retinal and intestinal transcripts cause an early-onset severe retinal dystrophy in microvillus inclusion disease subjects , 2021, Human Genetics.

[15]  U. Wolfrum,et al.  Roles for ELMOD2 and Rootletin in ciliogenesis , 2021, Molecular biology of the cell.

[16]  J. Nacher,et al.  Estradiol Regulates Polysialylated Form of the Neural Cell Adhesion Molecule Expression and Connectivity of O-LM Interneurons in the Hippocampus of Adult Female Mice , 2021, Neuroendocrinology.

[17]  U. Wolfrum,et al.  “Roles for ELMOD2 and Rootletin in Ciliogenesis” , 2021, bioRxiv.

[18]  Yoshiki Narimatsu,et al.  Global view of human protein glycosylation pathways and functions , 2020, Nature Reviews Molecular Cell Biology.

[19]  S. Dagogo-Jack,et al.  Role of ceramides in the pathogenesis of diabetes mellitus and its complications. , 2020, Journal of diabetes and its complications.

[20]  K. Bötzel,et al.  Loss‐of‐Function Variants in HOPS Complex Genes VPS16 and VPS41 Cause Early Onset Dystonia Associated with Lysosomal Abnormalities , 2020, Annals of neurology.

[21]  Shannon M. Conley,et al.  Syntaxin 3 is essential for photoreceptor outer segment protein trafficking and survival , 2020, Proceedings of the National Academy of Sciences.

[22]  Jeesoo Kim,et al.  Identification of a structurally dynamic domain for oligomer formation in rootletin. , 2020, Journal of molecular biology.

[23]  E. Chuluyan,et al.  Elucidating the mechanism of action of alpha-1-antitrypsin using retinal pigment epithelium cells exposed to high glucose. Potential use in diabetic retinopathy , 2020, PloS one.

[24]  R. Cummings,et al.  Cosmc-dependent mucin-type O-linked glycosylation is essential for podocyte function. , 2020, American journal of physiology. Renal physiology.

[25]  Runan Yao,et al.  ShinyGO: a graphical gene-set enrichment tool for animals and plants , 2019, Bioinform..

[26]  J. Shaw,et al.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2019, Diabetes research and clinical practice.

[27]  D. Lefeber,et al.  O-glycosylation disorders pave the road for understanding the complex human O-glycosylation machinery. , 2019, Current opinion in structural biology.

[28]  Xin Shi,et al.  O- glycosylation can regulate the proliferation and migration of human retinal microvascular endothelial cells through ZFR in high glucose condition. , 2019, Biochemical and biophysical research communications.

[29]  K. Palczewski,et al.  Human red and green cone opsins are O-glycosylated at an N-terminal Ser/Thr–rich domain conserved in vertebrates , 2019, The Journal of Biological Chemistry.

[30]  J. Novak,et al.  Glycosylation in health and disease , 2019, Nature Reviews Nephrology.

[31]  Anna C. Salzberg,et al.  O-GlcNAcylation alters the selection of mRNAs for translation and promotes 4E-BP1–dependent mitochondrial dysfunction in the retina , 2019, The Journal of Biological Chemistry.

[32]  F. Irazoqui,et al.  Biosynthesis of O-N-acetylgalactosamine glycans in the human cell nucleus , 2018, The Journal of Biological Chemistry.

[33]  Wei Wang,et al.  Diabetic Retinopathy: Pathophysiology and Treatments , 2018, International journal of molecular sciences.

[34]  Yizhi Liu,et al.  Alpha-1 Antitrypsin Attenuates M1 Microglia-Mediated Neuroinflammation in Retinal Degeneration , 2018, Front. Immunol..

[35]  C. Potilinski,et al.  Alpha‐1‐antitrypsin ameliorates inflammation and neurodegeneration in the diabetic mouse retina , 2018, Experimental eye research.

[36]  Xiao-Ming Gao,et al.  Aberrant Glycosylation Augments the Immuno-Stimulatory Activities of Soluble Calreticulin , 2018, Molecules.

[37]  N. Sheibani,et al.  O-Linked β-N-acetylglucosamine (O-GlcNAc) modification: a new pathway to decode pathogenesis of diabetic retinopathy. , 2018, Clinical science.

[38]  M. Hayden,et al.  ABCA8 Regulates Cholesterol Efflux and High-Density Lipoprotein Cholesterol Levels , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[39]  Jennifer K. Sun,et al.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. , 2017, JCI insight.

[40]  V. Couderc,et al.  SHG-specificity of cellular Rootletin filaments enables naïve imaging with universal conservation , 2017, Scientific Reports.

[41]  C. Vandenberg,et al.  The SNARE Protein Syntaxin 3 Confers Specificity for Polarized Axonal Trafficking in Neurons , 2016, PloS one.

[42]  L. Grinberg,et al.  Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment , 2016, Molecular Neurodegeneration.

[43]  A. Feigenspan,et al.  Functional Roles of Complexin 3 and Complexin 4 at Mouse Photoreceptor Ribbon Synapses , 2016, The Journal of Neuroscience.

[44]  W. Grizzle,et al.  Surveying the serologic proteome in a tissue‐specific kras(G12D) knockin mouse model of pancreatic cancer , 2016, Proteomics.

[45]  W. Choi,et al.  Increased O-GlcNAcylation of NF-κB Enhances Retinal Ganglion Cell Death in Streptozotocin-induced Diabetic Retinopathy , 2016, Current eye research.

[46]  M. Naash,et al.  Glycosylation of rhodopsin is necessary for its stability and incorporation into photoreceptor outer segment discs. , 2015, Human molecular genetics.

[47]  Zhaohui Xu,et al.  A Novel Mechanism of Regulating the ATPase VPS4 by Its Cofactor LIP5 and the Endosomal Sorting Complex Required for Transport (ESCRT)-III Protein CHMP5* , 2015, The Journal of Biological Chemistry.

[48]  F. Verbraak Neuroretinal Degeneration in Relation to Vasculopathy in Diabetes , 2014, Diabetes.

[49]  Xia Ding,et al.  Spatial Control of Proton Pump H,K-ATPase Docking at the Apical Membrane by Phosphorylation-coupled Ezrin-Syntaxin 3 Interaction* , 2014, The Journal of Biological Chemistry.

[50]  M. Wormald,et al.  The role and importance of glycosylation of acute phase proteins with focus on alpha-1 antitrypsin in acute and chronic inflammatory conditions. , 2014, Journal of proteome research.

[51]  N. Sheibani,et al.  Identification of O-GlcNAc Modification Targets in Mouse Retinal Pericytes: Implication of p53 in Pathogenesis of Diabetic Retinopathy , 2014, PloS one.

[52]  F. Wang,et al.  O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy. , 2014, International journal of molecular medicine.

[53]  Markus Aebi,et al.  N-linked protein glycosylation in the ER. , 2013, Biochimica et biophysica acta.

[54]  R. Simó,et al.  Somatostatin replacement: a new strategy for treating diabetic retinopathy. , 2013, Current medicinal chemistry.

[55]  G. Halliday,et al.  ABCA8 stimulates sphingomyelin production in oligodendrocytes. , 2013, The Biochemical journal.

[56]  Edoardo Midena,et al.  Retinal Layers Changes in Human Preclinical and Early Clinical Diabetic Retinopathy Support Early Retinal Neuronal and Müller Cells Alterations , 2013, Journal of diabetes research.

[57]  C. Sorenson,et al.  Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy , 2013, Molecular vision.

[58]  R. Cunha,et al.  Diabetes differentially affects the content of exocytotic proteins in hippocampal and retinal nerve terminals , 2010, Neuroscience.

[59]  I. Hirsch,et al.  Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications. , 2010, JAMA.

[60]  E. Sprecher,et al.  Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis. , 2009, Biochimica et biophysica acta.

[61]  R. Raman,et al.  Is neuronal dysfunction an early sign of diabetic retinopathy? Microperimetry and Spectral Domain Optical Coherence Tomography (SD-OCT) Study in individuals with diabetes, but no diabetic retinopathy , 2009, Eye.

[62]  Junxia Xie,et al.  Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra , 2008, Experimental Neurology.

[63]  Xianlin Han,et al.  Diabetes Alters Sphingolipid Metabolism in the Retina , 2006, Diabetes.

[64]  E. Geisert,et al.  Temporal changes in gene expression after injury in the rat retina. , 2004, Investigative ophthalmology & visual science.

[65]  M. Fukuda,et al.  Diabetes and the Accompanying Hyperglycemia Impairs Cardiomyocyte Calcium Cycling through Increased Nuclear O-GlcNAcylation* , 2003, Journal of Biological Chemistry.

[66]  V. Gouyer,et al.  1-Benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside Blocks the Apical Biosynthetic Pathway in Polarized HT-29 Cells* , 2003, Journal of Biological Chemistry.

[67]  R. Nagaraj,et al.  Enhancement of chaperone function of α-crystallin by methylglyoxal modification , 2003 .

[68]  K. Schey,et al.  High glucose and insulin promote O-GlcNAc modification of proteins, including α-tubulin , 2003 .

[69]  G. Denning,et al.  Calreticulin biosynthesis and processing in human myeloid cells: demonstration of signal peptide cleavage and N-glycosylation. , 1997, Blood.

[70]  R. Mcinnes,et al.  Mutation analysis of the ROM1 gene in retinitis pigmentosa. , 1995, Human molecular genetics.

[71]  R. Aebersold,et al.  Alpha A- and alpha B-crystallin in the retina. Association with the post-Golgi compartment of frog retinal photoreceptors. , 1994, The Journal of biological chemistry.

[72]  E. Abraham,et al.  Glycation mediated lens crystallin aggregation and cross-linking by various sugars and sugar phosphates in vitro. , 1993, Experimental eye research.

[73]  G. Hart,et al.  Vertebrate lens alpha-crystallins are modified by O-linked N-acetylglucosamine. , 1992, The Journal of biological chemistry.

[74]  C. Abeijon,et al.  Topography of initiation of N-glycosylation reactions. , 1990, The Journal of biological chemistry.

[75]  A. Zuddas,et al.  MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigra , 1989, Brain Research.

[76]  L. Chylack,et al.  Nonenzymatic glycation of human lens crystallin. Effect of aging and diabetes mellitus. , 1984, The Journal of clinical investigation.

[77]  C. Bardin,et al.  Ultrastructural changes in Leydig cells of streptozotocininduced diabetic rats , 1979, The Anatomical record.

[78]  S. Blumenthal Observations on Sodium Retention Related to Insulin Treatment of Experimental Diabetes , 1975, Diabetes.

[79]  A. Motala,et al.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 th edition , 2019 .

[80]  Guangji Wang,et al.  streptozotocin- induced diabetic rats , 2008 .

[81]  Xianlin Han,et al.  Diabetes Alters Sphingolipid Metabolism in the Retina A Potential Mechanism of Cell Death in Diabetic , 2006 .

[82]  K. Breen,et al.  The potential role of tau protein O-glycosylation in Alzheimer's disease. , 2004, Journal of Alzheimer's disease : JAD.

[83]  M. Miyagi,et al.  Intense light exposure changes the crystallin content in retina. , 2003, Experimental eye research.

[84]  J. E. Kudlow,et al.  The role of O-linked protein glycosylation in beta-cell dysfunction. , 2002, International journal of molecular medicine.